These studies indicate that the new regulatory axis composed of CircCwc27 and Pur-α may play a critical role in AD, and CircCwc27 may become a new therapeutic target for AD, and an effective tool for early diagnosis and predicting patient outcomes. The gene discussed is PURA; the disease is Alzheimer disease.